Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lumiera Health Inc V.NHP.H

Lumiera Health Inc. is a Canadian company that specializes in the development and commercialization of natural health products. Its brands consist of Holizen Laboratories, Awaye pain relief cream, and Bazzzics. Through its Holizen Laboratories division, the Company sells both oral and topical formulations to help manage a range of therapeutic needs, including a new generation of natural sleep... see more

TSXV:NHP.H - Post Discussion

Lumiera Health Inc > this thing is D.O.A.
View:
Post by FinSysOp on May 06, 2021 11:56am

this thing is D.O.A.

This anemic hot turd of a mess is the brainchild of some of quebecs dumbest business people. 

It is wonderful to see how a lousy board, and a bunch of slimeballs latch on to a public shell for self enrichment and fail at that...

Losers in life and losers in business.  

Stay toxic boys.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities